MSLNL
Mesothelin-like protein
Also known as: C16orf37, MPFL, MSLNL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96KJ4
- Gene
- MSLNL
- Ensembl
- ENSG00000162006
- Chromosome
- 16
- Canonical length
- 702 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in cell-matrix adhesion. Predicted to be located in membrane. Predicted to be active in cell surface. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
702 residues, UniProt reviewed canonical sequence.
>Q96KJ4|MSLNL
1 MAAAVTIPGP RIGALQSSGL TLLLSLAAHC SGPQAKVLSP GGLDASGANL WASANCSLLQ
61 GFWCQPASQL PRDQLSALIQ RLALLQVPLQ AWQLSCLANL ASRCGLQDDF TLHPPNLLLF
121 YNLSQVREAD CRAFIRRAAQ GDVELLSHLP DQRVALWRAA VACLVGAGLR LSASDQQLLG
181 ALVCDMDASS IGAADPHMLE NLRRCPRLTA AQRIALNSLL AGGKTSLGPP GSWTLEGLQA
241 LGPLATYISP HLWAQVQEAV GLGFFRSVVA SCQVGRLGQR EARCFVTSFL ESKTKPVSSR
301 PRLSTGNITA ATLRDDLFLV HYDCAELESC LDGCILRTNL DTLLQHLLPT ECQHVVKAKL
361 AQIYPQGLPE DQLRLITSLV YLYSRTEIGQ WSITSQDTVM ALLASDVALE NQTEAVLQKF
421 LEHNGTVSGA LLLAIGGTRL CWMSPHQIQT IHPQELRLAG ALDLSSCPQS RKDVLYTKAH
481 ETFGSSGTLA AYYRLMRPYL GGSPGGAQPP SPVPPGGAPV EELRHLAHAN ISMDIDTFTS
541 LNPLELQSLD VGNVTALLGH NVGDLQKARS HPTVRAWLRS LNSSTLGQLG LDASPTSPTG
601 PAHGTRGPPS TTHQVLHLVH TSGLPTNDAQ ASTSGSLWAP LGYLPLAMAL PCSLLCLLHW
661 GTCILVSVDS VASGWLGSQG SGAGKTEVLD SAGRPLGLTG QLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSLNL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 0.6 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 0.6 nTPM
- cerebral cortex: 0.5 nTPM
- basal ganglia: 0.2 nTPM
- stomach: 0.2 nTPM
- fallopian tube: 0.1 nTPM
- lung: 0.1 nTPM
Single-cell type
- epicardial cells: 80 nCPM
- retinal bipolar cells: 8.7 nCPM
- endometrial luminal cells: 5.8 nCPM
- endometrial glandular cells: 5.3 nCPM
- conjunctival goblet cells: 4.9 nCPM
- epididymal principal cells: 4.2 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.9 nTPM
- basal ganglia: 0.6 nTPM
- hippocampal formation: 0.3 nTPM
- white matter: 0.3 nTPM
- amygdala: 0.2 nTPM
- cerebellum: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.36
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSLNL as an antibody target. Whether an autoantibody or antibody against MSLNL could matter depends on whether native MSLNL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSLNL is annotated at the cell surface, where native MSLNL is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MSLNL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...